The Value of a QofE Beyond Standard EBITDA Normalizations
The Value of a QofE Beyond Standard EBITDA Normalizations
| Topic | EBITDA Normalization & QofE |
| Audience | PE Sponsors, Deal Teams, CFOs, Lenders |
| Stage | Pre-LOI Through Due Diligence |
| Applies To | Middle Market M&A Transactions |
- EBITDA normalization removes non-recurring items from reported earnings, but it does not assess whether the revenue and margins that remain are sustainable or accurately presented.
- Seller-prepared normalization adjustments are frequently overstated and require independent verification before they can be relied upon in valuation or debt underwriting.
- A Quality of Earnings review goes further: it evaluates revenue quality, customer concentration, accounting policy, working capital, and the assumptions behind management's projections.
- At 7x to 10x EBITDA multiples, a $500,000 overstatement in adjusted EBITDA translates directly into $3.5 to $5 million in purchase price exposure.
Every middle market PE transaction arrives with a seller-prepared adjusted EBITDA bridge. The logic is familiar: remove the owner's personal expenses, add back a one-time legal charge, normalize for a non-recurring contract, and present the result as the business's true run-rate earnings. This process is necessary. The problem is that deal teams too often treat it as sufficient.
EBITDA normalization answers one question: what should be removed from reported earnings? It does not evaluate whether the revenue underlying those earnings is concentrated in one or two customers with expiring contracts, whether the company's revenue recognition policies are conservative or aggressive, or whether growing the business will require working capital that compresses free cash flow well below what the EBITDA multiple implies. Those questions require a Quality of Earnings review, and when sponsors skip that step, they are underwriting against a number they have not fully tested.
Where Normalization Falls Short
Seller adjustments, including excess owner compensation, one-time costs, and pro forma revenue from contracts under negotiation, are almost always presented optimistically. Independent QofE work routinely finds that a meaningful share of seller-presented add-backs are either partially supportable or unsupported when subjected to documentary review.
At an 8x purchase price multiple, a $750,000 reduction in independently supportable EBITDA represents $6 million in overpayment. That gap does not close through post-close operational improvement, as it is locked into the deal structure at signing.
Beyond the adjustments themselves, normalization leaves the most consequential risks unexamined. Revenue concentration, contract renewal risk, aggressive cost capitalization, and working capital dynamics that imply a cash-consumptive business at growth, none of these appear in a normalization bridge. They appear in a QofE review, and they routinely change how a sponsor structures a deal, prices leverage, or sizes a working capital peg.
What a QofE Review Actually Provides
A Quality of Earnings engagement independently verifies the normalization adjustments, then goes further: it disaggregates revenue by customer and contract to assess concentration and renewal risk, evaluates whether accounting policies are consistent with applicable standards, calculates a normalized working capital requirement, and tests management's projections against historical performance. The result is an independently supported EBITDA figure that a deal team, and its lenders, can underwrite against with confidence.
The cost of a QofE review is small relative to the exposure it addresses. The transactions most likely to underperform are not those in which due diligence surfaced a problem. They are the ones in which the sponsor relied on normalized EBITDA and discovered the gap only after close.
Summary
EBITDA normalization is a necessary step in PE deal analysis, but it is not a substitute for a Quality of Earnings review. Normalization removes non-recurring items; it does not assess the quality or sustainability of what remains. In middle market transactions priced at 7x to 10x EBITDA, the difference between seller-adjusted and independently supported earnings has direct and material consequences for purchase price, leverage, and post-close performance. A QofE engagement provides the independent verification and broader analytical coverage that normalization alone cannot.
The Value of a QofE Beyond Standard EBITDA Normalizations
The Value of a QofE Beyond Standard EBITDA Normalizations
Every middle market PE transaction arrives with a seller-prepared adjusted EBITDA bridge. The logic is familiar: remove the owner's personal expenses, add back a one-time legal charge, normalize for a non-recurring contract, and present the result as the business's true run-rate earnings. This process is necessary. The problem is that deal teams too often treat it as sufficient.
EBITDA normalization answers one question: what should be removed from reported earnings? It does not evaluate whether the revenue underlying those earnings is concentrated in one or two customers with expiring contracts, whether the company's revenue recognition policies are conservative or aggressive, or whether growing the business will require working capital that compresses free cash flow well below what the EBITDA multiple implies. Those questions require a Quality of Earnings review, and when sponsors skip that step, they are underwriting against a number they have not fully tested.
Where Normalization Falls Short
Seller adjustments, including excess owner compensation, one-time costs, and pro forma revenue from contracts under negotiation, are almost always presented optimistically. Independent QofE work routinely finds that a meaningful share of seller-presented add-backs are either partially supportable or unsupported when subjected to documentary review.
At an 8x purchase price multiple, a $750,000 reduction in independently supportable EBITDA represents $6 million in overpayment. That gap does not close through post-close operational improvement, as it is locked into the deal structure at signing.
Beyond the adjustments themselves, normalization leaves the most consequential risks unexamined. Revenue concentration, contract renewal risk, aggressive cost capitalization, and working capital dynamics that imply a cash-consumptive business at growth, none of these appear in a normalization bridge. They appear in a QofE review, and they routinely change how a sponsor structures a deal, prices leverage, or sizes a working capital peg.
What a QofE Review Actually Provides
A Quality of Earnings engagement independently verifies the normalization adjustments, then goes further: it disaggregates revenue by customer and contract to assess concentration and renewal risk, evaluates whether accounting policies are consistent with applicable standards, calculates a normalized working capital requirement, and tests management's projections against historical performance. The result is an independently supported EBITDA figure that a deal team, and its lenders, can underwrite against with confidence.
The cost of a QofE review is small relative to the exposure it addresses. The transactions most likely to underperform are not those in which due diligence surfaced a problem. They are the ones in which the sponsor relied on normalized EBITDA and discovered the gap only after close.
Summary
EBITDA normalization is a necessary step in PE deal analysis, but it is not a substitute for a Quality of Earnings review. Normalization removes non-recurring items; it does not assess the quality or sustainability of what remains. In middle market transactions priced at 7x to 10x EBITDA, the difference between seller-adjusted and independently supported earnings has direct and material consequences for purchase price, leverage, and post-close performance. A QofE engagement provides the independent verification and broader analytical coverage that normalization alone cannot.
RECENT NEWS
Q3 2026 Mergers & Acquisitions Market Update
The McLean Group’s Q3 2026 M&A Insider Report tracks 137 transactions across Defense, Government & Intelligence; Physical & Cyber Security; Critical Infrastructure; and Maritime Transport & Facilities, down from 167 in Q2. Deal activity slowed as the Federal Reserve raised its benchmark rate to 3.75%–4.00%, its first hike in more than three years, and the 10-year Treasury yield passed 5%. Large strategic deals continued, led by GE Aerospace’s pending $11.75B acquisition of Consolidated Precision Products, while Congress funded the government through December 11 under a continuing resolution, deferring the FY2027 appropriations fight until after the midterms. […]
SBA 7(a) Change-of-Ownership Loans Now Require an Independent Quality of Earnings Report
Effective October 1, 2026, the SBA requires 7(a) lenders to obtain an independent quality of earnings report on Initial Acquisition and Business Expansion change-of-ownership loans where the business purchase price is $3 million or more. The report must be commissioned by and for the benefit of the lender, and lenders must size the loan on its normalized EBITDA instead of the seller’s add-backs. This article explains what the report has to contain, who is exempt, how disallowed add-backs can shrink a loan or force a larger equity injection or a renegotiated price, and why sellers who understand their add-backs before going to market are better positioned for a smoother financing process. […]
Fairness Opinions: What Boards Should Know Before They Sign
A fairness opinion is an independent assessment of whether the financial terms of a transaction are fair to shareholders, but it speaks to how a board reached its decision rather than whether the decision was right. In this article, The McLean Group’s Valuation Advisory team examines what a fairness opinion is and is not, the three protections it provides to directors, and the situations that most often call for one: conflicts, complex consideration, multiple share classes, and the absence of a competitive process. For boards approaching a significant transaction, engaging an opinion early gives directors a record built while the analysis can still inform the outcome. […]